A 53-patient study showed that the use of Glaukos' iStent device in combination with topical travoprost for treating patients with open-angle glaucoma led to a 35% mean reduction in intraocular pressure at 18 months without device-related adverse events. After a year, the combined treatment demonstrated intraocular pressure of less than or equal to 18 mm Hg in 100% of eyes and intraocular pressure of less than or equal to 15 mm Hg in 87% of eyes.
Study shows positive results for Glaukos' iStent plus topical travoprost
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.